Genetically engineered mice in drug development

J N Livingston1

  • 1Bayer Corporation, West Haven, CT 06516-4175, USA.

Insights

Transgenic animal models aid drug development for complex metabolic diseases like type 2 diabetes and obesity. These models evaluate molecular targets in physiological conditions, overcoming challenges posed by polygenic and non-genetic factors.

Area of Science:

  • Pharmacology and Endocrinology
  • Genetics and Molecular Biology

Background:

  • Complex metabolic diseases, including type 2 diabetes and obesity, pose significant challenges for pharmaceutical drug development.
  • The polygenic nature and influence of non-genetic factors complicate the identification of critical molecular targets.
  • Current therapeutic strategies face limitations in addressing these multifaceted conditions.

Purpose of the Study:

  • To explore the utility of transgenic animal models in understanding and developing therapies for type 2 diabetes and obesity.
  • To evaluate the advantages and limitations of using transgenic animals for drug development in metabolic diseases.
  • To provide an overview of recent transgenic study findings relevant to type 2 diabetes and obesity.

Main Methods:

  • Utilizing transgenic animal models to investigate metabolic and hormone signaling pathways.
  • Assessing molecular targets under physiological conditions within these models.
  • Reviewing existing literature and data from transgenic studies.

Main Results:

  • Transgenic models offer a physiological platform for evaluating drug targets.
  • These models help elucidate complex molecular processes in metabolic diseases.
  • Recent studies provide insights into potential therapeutic interventions.

Conclusions:

  • Transgenic animal models are valuable tools in pharmaceutical research for metabolic diseases.
  • They facilitate the identification and validation of novel drug targets.
  • Further research using these models can accelerate the development of effective treatments for type 2 diabetes and obesity.